Answers are grounded in this paper and cite their sources.
Contamination of biomedical products with pathogenic microorganisms (bacteria, fungi, and viruses) is one of the main causes of hospital-acquired infections (HAI), and a major burden to the healthcare system. The development of biomaterials that can hamper the contamination of surfaces is vital to decrease patient-related infections in healthcare settings. In this landscape, this review identifies some of the latest antimicrobial strategies while paying particular attention to emerging antimicrobial biomaterials and nature-inspired antimicrobial surface topographies, which are rapidly finding application in the fabrication of biomedical engineering constructs.
No takes yet. Share an insight, caveat, or question.
Sheridan et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: